MedTrace Logo

Primitive Immunodeficiency and Pregnancy

NCT04581460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2026-03-09

No results posted yet for this study

Summary

The management of patients with primary immune deficiency is increasingly codified, however contraception and pregnancy have not yet extensively studied or codified, and the medical monitoring and the prevention of infectious complications thus remains at the discretion of the practitioner.

The aim the research is to study the obstetric features and outcome of patients with primary immune defects.

Conditions

  • Primary Immune Deficiency

Interventions

OTHER

Questionnaire

Questionnaire intended for patients on the course of pregnancy and postpartum, the neonatal period and contraceptive modalities.

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Elise Mallart · Assistance Publique - Hôpitaux de Paris

  • Caroline Charlier-Woerther, MD · Assistance Publique - Hôpitaux de Paris

  • Nizar Mahlaoui, MD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2022-04-25
Completion
2022-04-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04581460 on ClinicalTrials.gov